Biology Reference
In-Depth Information
[13] Ciavarra RP, Stephens A, Nagy S, Sekellick M, Steel C. Evaluation of immunological
paradigms in a virus model: are dendritic cells critical for antiviral immunity and viral
clearance? J Immunol 2006;177(1):492-500.
[14] Kassim SH, Rajasagi NK, Zhao XY, Chervenak R, Jennings SR. In vivo ablation of CD11c-
positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection
and diminishes NK and T-cell responses. J Virol 2006;80(8):3985-93.
[15] Liu CH, Fan YT, Dias A, Esper L, Corn RA, Bafica A, et al. Cutting edge: dendritic cells
are essential for in vivo IL-12 production and development of resistance against
Toxoplasma gondii infection in mice. J Immunol 2006;177(1):31-5.
[16] Steel CD, Hahto SM, Ciavarra RP. Peripheral dendritic cells are essential for both the in-
nate and adaptive antiviral immune responses in the central nervous system. Virology
2009;387(1):117-26.
[17] van Rijt LS, Jung S, KleinJan A, Vos N, Willart M, Duez C, et al. In vivo depletion of lung
CD11c(+) dendritic cells during allergen challenge abrogates the characteristic features
of asthma. J Exp Med 2005;201(6):981-91.
[18] Murillo O, Dubrot J, Palazon A, Arina A, Azpilikueta A, Alfaro C, et al. In vivo depletion
of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb. Eur J Immunol
2009;39(9):2424-36.
[19] Teichmann LL, Ols ML, Kashgarian M, Reizis B, Kaplan DH, Shlomchik MJ. Dendritic
cells in lupus are not required for activation of T and B cells but promote their expan-
sion, resulting in tissue damage. Immunity 2010;33(6):967-78.
[20] Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature
1998;392(6673):245-52.
[21] Steinman RM, Inaba K, Turley S, Pierre P, Mellman I. Antigen capture, processing,
and presentation by dendritic cells: recent cell biological studies. Hum Immunol
1999;60(7):562-7.
[22] Osorio F, Reis C. e Sousa, Myeloid C-type lectin receptors in pathogen recognition and
host defense. Immunity 2011;34(5):651-64.
[23] Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol
2002;20:197-216.
[24] Kaisho T, Akira S. Toll-like receptors as adjuvant receptors. Biochim Biophys Acta
2002;1589(1):1-13.
[25] Joffre O, Nolte MA, Sporri R, Reis e Sousa C. Inflammatory signals in dendritic cell acti-
vation and the induction of adaptive immunity. Immunol Rev 2009;227(1):234-47.
[26] Ackerman AL, Cresswell P. Regulation of MHC class I transport in human dendritic
cells and the dendritic-like cell line KG-1. J Immunol 2003;170(8):4178-88.
[27] Chow A, Toomre D, Garrett W, Mellman I. Dendritic cell maturation triggers ret-
rograde MHC class II transport from lysosomes to the plasma membrane. Nature
2002;418(6901):988-94.
[28] Gokmen MR, Lombardi G, Lechler RI. The importance of the indirect pathway of al-
lorecognition in clinical transplantation. Curr Opin Immunol 2008;20(5):568-74.
[29] Medzhitov R, Janeway Jr CA. How does the immune system distinguish self from
nonself ? Semin Immunol 2000;12(3):185-8; discussion 257-344.
[30] Wilhelm K, Ganesan J, Muller T, Durr C, Grimm M, Beilhack A, et al. Graft-versus-host
disease is enhanced by extracellular ATP activating P2X7R. Nat Med 2010;16(12):1434-8.
[31] Kwan WH, Hashimoto D, Paz-Artal E, Ostrow K, Greter M, Raedler H, et al. Antigen-
presenting cell-derived complement modulates graft-versus-host disease. J Clin Invest
2012;122(6):2234-8.
[32] Matte CC, Liu J, Cormier J, Anderson BE, Athanasiadis I, Jain D, et al. Donor APCs are
required for maximal GVHD but not for GVL. Nat Med 2004;10(9):987-92.
[33] Wang X, Li H, Matte-Martone C, Cui W, Li N, Tan HS, et al. Mechanisms of antigen
presentation to T cells in murine graft-versus-host disease: cross-presentation and the
appearance of cross-presentation. Blood 2011;118(24):6426-37.
[34] Man S, Salter RD, Engelhard VH. Role of endogenous peptide in human alloreactive
cytotoxic T cell responses. Int Immunol 1992;4(3):367-75.
[35] Crumpacker DB, Alexander J, Cresswell P, Engelhard VH. Role of endogenous peptides
in murine allogeneic cytotoxic T cell responses assessed using transfectants of the
antigen-processing mutant 174xCEM.T2. J Immunol 1992;148(10):3004-11.
[36] Aosai F, Ohlen C, Ljunggren HG, Hoglund P, Franksson L, Ploegh H, et al. Different
types of allospecific CTL clones identified by their ability to recognize peptide loading-
defective target cells. Eur J Immunol 1991;21(11):2767-74.
[37] Obst R, Netuschil N, Klopfer K, Stevanovic S, Rammensee HG. The role of peptides in T
cell alloreactivity is determined by self-major histocompatibility complex molecules.
J Exp Med 2000;191(5):805-12.
[38] Matzinger P, Bevan MJ. Hypothesis: why do so many lymphocytes respond to major
histocompatibility antigens? Cell Immunol 1977;29(1):1-5.
189
Search WWH ::




Custom Search